Profile data is unavailable for this security.
About the company
Alpa Laboratories Limited is an India-based company, which is engaged in manufacturing and selling pharmaceutical finished dosage forms. The Company’s product range includes a wide variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
- Revenue in INR (TTM)1.15bn
- Net income in INR178.77m
- Incorporated1988
- Employees318.00
- LocationAlpa Laboratories Ltd33/2 Pigdamber, A.B. Road, RauINDORE 453446IndiaIND
- Phone+91 7 314294567
- Fax+91 7 314294444
- Websitehttp://www.alpalabs.in/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Krebs Biochemicals And Industries Ltd | 499.09m | -208.21m | 1.57bn | 210.00 | -- | -- | -- | 3.15 | -9.50 | -9.50 | 22.86 | -- | -- | -- | -- | 2,376,624.00 | -- | -18.88 | -- | -29.04 | 86.28 | 11.95 | -41.72 | -59.37 | -- | -3.78 | -- | -- | -12.68 | 9.07 | 44.55 | -- | 28.63 | -- |
| Bal Pharma Ltd | 3.27bn | 35.19m | 1.59bn | -- | 46.19 | -- | 11.71 | 0.4847 | 2.17 | 2.17 | 209.85 | -- | -- | -- | -- | -- | -- | 0.1785 | -- | 0.4782 | 44.02 | 43.81 | 1.08 | 0.1865 | -- | 1.34 | -- | 132.38 | 8.18 | 7.54 | -54.17 | -1.56 | 31.09 | 0.00 |
| Mangalam Drugs and Organics Ltd | 3.57bn | -169.87m | 1.59bn | 523.00 | -- | -- | -- | 0.4459 | -10.74 | -10.74 | 225.21 | -- | -- | -- | -- | 6,834,930.00 | -- | 3.70 | -- | 6.50 | 26.38 | 29.07 | -4.75 | 2.87 | -- | -0.5682 | -- | -- | -17.47 | 5.91 | -93.54 | -42.32 | 11.78 | -- |
| Vaishali Pharma Ltd | 801.21m | 58.38m | 1.69bn | -- | 30.62 | -- | 26.61 | 2.11 | 5.15 | 5.15 | 68.64 | -- | -- | -- | -- | -- | -- | 3.32 | -- | 8.64 | 17.72 | 15.06 | 7.29 | 3.71 | -- | 4.37 | -- | -- | -8.12 | 0.5072 | 64.12 | 52.62 | -4.18 | -- |
| Alpa Laboratories Limited | 1.15bn | 178.77m | 2.03bn | 318.00 | 11.31 | -- | 10.23 | 1.77 | 8.54 | 8.54 | 54.78 | -- | -- | -- | -- | 3,610,371.00 | -- | 5.39 | -- | 6.71 | 35.30 | 33.85 | 15.57 | 7.88 | -- | 109.23 | -- | -- | -17.20 | 8.14 | -10.71 | 34.99 | -10.58 | -- |
| Bafna Pharmaceuticals Ltd | 1.53bn | 112.65m | 2.03bn | 588.00 | 17.44 | -- | 12.32 | 1.33 | 4.93 | 4.93 | 65.88 | -- | -- | -- | -- | 2,607,335.00 | -- | 0.228 | -- | 0.3636 | 30.53 | 34.36 | 7.35 | 0.3193 | -- | 4.72 | -- | -- | 35.60 | 19.60 | 117.36 | -- | 130.43 | -- |
| SMS Lifesciences India Ltd | 2.96bn | 49.05m | 2.04bn | 567.00 | 41.59 | -- | 12.72 | 0.6897 | 16.23 | 16.23 | 978.01 | -- | -- | -- | -- | 5,218,087.00 | -- | 5.33 | -- | 8.84 | 29.00 | 26.60 | 0.6645 | 4.99 | -- | 0.8533 | -- | 2.32 | -9.77 | 7.73 | -54.65 | 12.01 | 69.24 | -- |
| Vaidya Sane Ayurved Laboratories Ltd | 1.05bn | 36.30m | 2.11bn | 632.00 | 58.02 | 3.85 | 31.66 | 2.02 | 3.46 | 3.46 | 99.55 | 52.12 | 1.74 | 11.90 | 20.17 | 1,654,093.00 | 6.04 | -- | 7.39 | -- | 71.79 | -- | 3.47 | -- | 2.57 | 16.25 | 0.0683 | -- | 32.55 | -- | 49.62 | -- | -- | -- |
